Table 7 Estimates of clinical impact
| Â | Affected patellar reflex | Respiratory depression | Skipped or delayed dose | Calcium gluconate use |
|---|---|---|---|---|
Incidence amongst 9556 women | 1.6% | 1.3% | 3.6% | 0.18% |
Number of pre-eclamptic/eclamptic women needed to treat to experience one incidence (i.e., number needed to harm) | 61 | 77 | 27 | 555 |
Scenario: A hospital delivers 5000 women annually. Assuming a rate of PE/E of 5%, 250 women annually will require treatment with magnesium sulfate. | ||||
Frequency of 1 case (months) | 2.9 months | 3.7 months | 1.3 months | 26.7 months |